329 related articles for article (PubMed ID: 33519523)
1. The Role of Glycocalyx and Caveolae in Vascular Homeostasis and Diseases.
Potje SR; Paula TD; Paulo M; Bendhack LM
Front Physiol; 2020; 11():620840. PubMed ID: 33519523
[TBL] [Abstract][Full Text] [Related]
2. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae.
Peterson TE; Poppa V; Ueba H; Wu A; Yan C; Berk BC
Circ Res; 1999 Jul; 85(1):29-37. PubMed ID: 10400908
[TBL] [Abstract][Full Text] [Related]
3. Pro-atherosclerotic disturbed flow disrupts caveolin-1 expression, localization, and function via glycocalyx degradation.
Harding IC; Mitra R; Mensah SA; Herman IM; Ebong EE
J Transl Med; 2018 Dec; 16(1):364. PubMed ID: 30563532
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiological Role of Caveolae in Hypertension.
Lian X; Matthaeus C; Kaßmann M; Daumke O; Gollasch M
Front Med (Lausanne); 2019; 6():153. PubMed ID: 31355199
[TBL] [Abstract][Full Text] [Related]
5. Reduced caveolae density in arteries of SHR contributes to endothelial dysfunction and ROS production.
Potje SR; Grando MD; Chignalia AZ; Antoniali C; Bendhack LM
Sci Rep; 2019 Apr; 9(1):6696. PubMed ID: 31040342
[TBL] [Abstract][Full Text] [Related]
6. Subcellular localization of oxidants and redox modulation of endothelial nitric oxide synthase.
Maron BA; Michel T
Circ J; 2012; 76(11):2497-512. PubMed ID: 23075817
[TBL] [Abstract][Full Text] [Related]
7. The role of HYAL2 in LSS-induced glycocalyx impairment and the PKA-mediated decrease in eNOS-Ser-633 phosphorylation and nitric oxide production.
Kong X; Chen L; Ye P; Wang Z; Zhang J; Ye F; Chen S
Mol Biol Cell; 2016 Dec; 27(25):3972-3979. PubMed ID: 27798230
[TBL] [Abstract][Full Text] [Related]
8. Caveolae, caveolin and control of vascular tone: nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF) regulation.
Rath G; Dessy C; Feron O
J Physiol Pharmacol; 2009 Oct; 60 Suppl 4():105-9. PubMed ID: 20083858
[TBL] [Abstract][Full Text] [Related]
9. Caveolin-1 Regulates Atherogenesis by Attenuating Low-Density Lipoprotein Transcytosis and Vascular Inflammation Independently of Endothelial Nitric Oxide Synthase Activation.
Ramírez CM; Zhang X; Bandyopadhyay C; Rotllan N; Sugiyama MG; Aryal B; Liu X; He S; Kraehling JR; Ulrich V; Lin CS; Velazquez H; Lasunción MA; Li G; Suárez Y; Tellides G; Swirski FK; Lee WL; Schwartz MA; Sessa WC; Fernández-Hernando C
Circulation; 2019 Jul; 140(3):225-239. PubMed ID: 31154825
[TBL] [Abstract][Full Text] [Related]
10. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.
Mitra R; O'Neil GL; Harding IC; Cheng MJ; Mensah SA; Ebong EE
Curr Atheroscler Rep; 2017 Nov; 19(12):63. PubMed ID: 29127504
[TBL] [Abstract][Full Text] [Related]
11. Endothelial nitric oxide synthase, caveolae and the development of atherosclerosis.
Shaul PW
J Physiol; 2003 Feb; 547(Pt 1):21-33. PubMed ID: 12562964
[TBL] [Abstract][Full Text] [Related]
12. The Glycocalyx and Its Role in Vascular Physiology and Vascular Related Diseases.
Weinbaum S; Cancel LM; Fu BM; Tarbell JM
Cardiovasc Eng Technol; 2021 Feb; 12(1):37-71. PubMed ID: 32959164
[TBL] [Abstract][Full Text] [Related]
13. Regulation and function of endothelial glycocalyx layer in vascular diseases.
Sieve I; Münster-Kühnel AK; Hilfiker-Kleiner D
Vascul Pharmacol; 2018 Jan; 100():26-33. PubMed ID: 28919014
[TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae.
Li Q; Zhang Q; Wang M; Liu F; Zhao S; Ma J; Luo N; Li N; Li Y; Xu G; Li J
Arch Biochem Biophys; 2007 Oct; 466(2):250-9. PubMed ID: 17662956
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide, caveolae, and vascular pathology.
Li XA; Everson W; Smart EJ
Cardiovasc Toxicol; 2006; 6(1):1-13. PubMed ID: 16845178
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury.
van Golen RF; van Gulik TM; Heger M
Free Radic Biol Med; 2012 Apr; 52(8):1382-402. PubMed ID: 22326617
[TBL] [Abstract][Full Text] [Related]
17. TNF-alpha potentiates protein-tyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells.
Yang B; Rizzo V
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H954-62. PubMed ID: 17028163
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits flow-mediated activation of endothelial nitric-oxide synthase by altering cholesterol content in caveolae.
Lungu AO; Jin ZG; Yamawaki H; Tanimoto T; Wong C; Berk BC
J Biol Chem; 2004 Nov; 279(47):48794-800. PubMed ID: 15383526
[TBL] [Abstract][Full Text] [Related]
19. Nitric Oxide Donors as Potential Drugs for the Treatment of Vascular Diseases Due to Endothelium Dysfunction.
Paulo M; Costa DEFR; Bonaventura D; Lunardi CN; Bendhack LM
Curr Pharm Des; 2020; 26(30):3748-3759. PubMed ID: 32427079
[TBL] [Abstract][Full Text] [Related]
20. Caveolae, estrogen and nitric oxide.
Zhu W; Smart EJ
Trends Endocrinol Metab; 2003 Apr; 14(3):114-7. PubMed ID: 12670736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
